Biotech Stocks

MYOS RENS Technology (MYOS) Stock Fires Up to the Roof; Here’s Why

MYOS RENS Technology (MYOS) stock is soaring — up over 50% since news broke today that The Vitamin Shoppe is picking up its product …

A Glimpse Into the Cannabis Stocks’ World

Investing in the marijuana industry may have seemed taboo a few years back, but as more states are making recreational marijuana legal with …

Cartel Investigation Drags Teva Pharmaceutical (TEVA) Stock Down; Evercore Weighs In

Israeli generic drug manufacturer Teva (TEVA) was named by the Washington Post as being one of more than a dozen subjects of a …

Marinus Pharmaceuticals (MRNS) Sparks Optimism Among Investors; Here’s Why

Marinus Pharmaceuticals (MRNS) just released positive results from its Phase 2 clinical trials, which evaluated ganaxolone intravenous (IV) (called the Magnolia Study) and …

Does Amarin’s (AMRN) Impending FDA Decision Matter?

Blogger Christiana Friedman says the FDA decision for Amarin’s (AMRN) drug Vascepa might not be the make or break for the company. In …

AcelRx (ACRX) Tumbles After Stock Offering Prices at Deep Discount

Shares of biotechnology company AcelRx (ACRX) are tumbling – down nearly 17% as of this writing. The reason?

Why OncoSec Medical (ONCS) Stock Crashed Today

Some investors might love biotech stocks for their lottery ticket-like returns when a company strikes medical gold. A lottery ticket, however, costs only …

Here’s Why AcelRx Pharmaceuticals (ACRX) Stock Skyrocketed Today

On a day like today, when the entire stock market is under pressure, you must have done something right to see your stock …

Spooked Investors Send Trevena (TVRN) Stock Spiraling as the Company’s Lead Drug Candidate Faces Major Downfall

The US Food and Drug Administration (FDA) puts the needle in the arm of drug company Trevena (TRVN). The agency’s critical briefing documents …

Amarin (AMRN) Stock Gaining as This Analyst Doubles Price Target

Can you feel the ground moving beneath your feet? Amarin (AMRN) share price has jumped nearly seven-folds in value over the past 2 …